152 related articles for article (PubMed ID: 9568038)
1. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture.
Bárcena J; Blasco R
Virology; 1998 Apr; 243(2):396-405. PubMed ID: 9568038
[TBL] [Abstract][Full Text] [Related]
2. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
Ramsey-Ewing A; Moss B
Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
[TBL] [Abstract][Full Text] [Related]
3. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
Carroll MW; Moss B
Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
[TBL] [Abstract][Full Text] [Related]
4. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters].
Loparev VN; Chernos VI
Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
6. Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death.
Kohno A; Emi N; Kasai M; Tanimoto M; Saito H
Gene Ther; 1998 Mar; 5(3):415-8. PubMed ID: 9614563
[TBL] [Abstract][Full Text] [Related]
7. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants.
Winslow BJ; Kalabat DY; Brown SM; Cochran MD; Collisson EW
Vet Microbiol; 2005 Nov; 111(1-2):1-13. PubMed ID: 16181751
[TBL] [Abstract][Full Text] [Related]
8. Selection of recombinant vaccinia viruses (Tian Tan strain) expressing hepatitis B virus surface antigen by using beta-galactosidase as a marker.
Liu GQ; Cao X; Zhu JM; Ren GF; Li HM; Xie YX; Peng W
Sci China B; 1990 Feb; 33(2):188-97. PubMed ID: 2111142
[TBL] [Abstract][Full Text] [Related]
9. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
Ramsey-Ewing AL; Moss B
Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
[TBL] [Abstract][Full Text] [Related]
10. Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin.
Winslow BJ; Cochran MD; Holzenburg A; Sun J; Junker DE; Collisson EW
Virus Res; 2003 Dec; 98(1):1-15. PubMed ID: 14609625
[TBL] [Abstract][Full Text] [Related]
11. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
12. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
Altman-Hamamdzic S; Groseclose C; Ma JX; Hamamdzic D; Vrindavanam NS; Middaugh LD; Parratto NP; Sallee FR
Gene Ther; 1997 Aug; 4(8):815-22. PubMed ID: 9338010
[TBL] [Abstract][Full Text] [Related]
13. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability.
Casales E; Rodriguez-Madoz JR; Ruiz-Guillen M; Razquin N; Cuevas Y; Prieto J; Smerdou C
Virology; 2008 Jun; 376(1):242-51. PubMed ID: 18442838
[TBL] [Abstract][Full Text] [Related]
14. Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein.
Hahn J; Park SH; Song JY; An SH; Ahn BY
J Virol Methods; 2001 Apr; 93(1-2):49-56. PubMed ID: 11311343
[TBL] [Abstract][Full Text] [Related]
15. [Insertion mutants of the vaccinia virus. The effect of inactivating E7R and D8L genes on the biological properties of the virus].
Chernos VI; Vovk TS; Ivanova ON; Antonova TP; Loparev VN
Mol Gen Mikrobiol Virusol; 1993; (2):30-4. PubMed ID: 8515749
[TBL] [Abstract][Full Text] [Related]
16. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by a postbinding step of vaccinia virus entry into Chinese hamster ovary cells.
Ramsey-Ewing A; Moss B
Virology; 1998 Mar; 242(1):138-49. PubMed ID: 9501038
[TBL] [Abstract][Full Text] [Related]
18. A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein.
Lin HX; Huang DY; Wang Y; Lu CP; Fan HJ
Vaccine; 2011 Sep; 29(40):7027-34. PubMed ID: 21807055
[TBL] [Abstract][Full Text] [Related]
19. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.
Wyatt LS; Moss B; Rozenblatt S
Virology; 1995 Jun; 210(1):202-5. PubMed ID: 7793072
[TBL] [Abstract][Full Text] [Related]
20. Construction of recombinant avian infectious laryngotracheitis virus expressing the beta-galactosidase gene and DNA sequencing of the insertion region.
Guo P; Scholz E; Maloney B; Welniak E
Virology; 1994 Aug; 202(2):771-81. PubMed ID: 8030240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
